Renal Cancer Without Primary Cancer in the Kidney: Extra-Renal TFE3 Translocation Associated Renal Cell Carcinoma.
- Published in:
- Kidney Cancer (2468-4562), 2021, v. 5, n. 2, p. 107, doi. 10.3233/KCA-200102
- By:
- Publication type:
- Article
Works matching IS 24684562 AND DT 2021 AND VI 5 AND IP 2
Results: 6
1
2
Clinical Trials Corner: A New Look at Cytoreductive Nephrectomy.
- Published in:
- Kidney Cancer (2468-4562), 2021, v. 5, n. 2, p. 113, doi. 10.3233/KCA-210000
- By:
- Publication type:
- Article
3
Twitter as a Tool to Spread Communication Regarding Genitourinary Cancers During the COVID-19 Pandemic.
- Published in:
- Kidney Cancer (2468-4562), 2021, v. 5, n. 2, p. 73, doi. 10.3233/KCA-210115
- By:
- Publication type:
- Article
4
PBRM1 Mutations as a Predictive Biomarker for Immunotherapy in Metastatic Renal Cell Carcinoma: A Systematic Review.
- Published in:
- Kidney Cancer (2468-4562), 2021, v. 5, n. 2, p. 79, doi. 10.3233/KCA-210111
- By:
- Publication type:
- Article
5
Impact of SARS-CoV-2 Pandemic on Kidney Cancer Management.
- Published in:
- Kidney Cancer (2468-4562), 2021, v. 5, n. 2, p. 93, doi. 10.3233/KCA-210112
- By:
- Publication type:
- Article
6
Nivolumab: 5 Years Since FDA Approval of the First Checkpoint Inhibitor for Renal Cell Carcinoma.
- Published in:
- Kidney Cancer (2468-4562), 2021, v. 5, n. 2, p. 63, doi. 10.3233/KCA-200109
- By:
- Publication type:
- Article